Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06558370

Bladder Distension for Pain Relief in Nullliparous Patients Undergoing Diagnostic Office Hysteroscopy

Bladder Filling for Pain Relief in Nullliparous Patients Undergoing Diagnostic Office Hysteroscopy

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
114 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 48 Years
Healthy volunteers
Not accepted

Summary

This study is conducted to assess whether the passive uterine straightening of the uterus by means of bladder filling is associated with less pain experienced by nulliparous women during office hysteroscopy.

Detailed description

A randomized controlled study revealed that bladder filling before office hysteroscopy was associated with less pain experienced by parous women . On the other hand, a randomized study revealed that misoprostol was more effective than bladder filling in minimizing the pain experienced by postmenopausal women during office hysteroscopy. Till now , no studies were conducted to detect the effect of bladder filling on the pain experienced by nulliparous women during office hysteroscopy.

Conditions

Interventions

TypeNameDescription
OTHEREmpty bladder groupPatients in the empty bladder group will be instructed to empty the bladder immediately before the procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is empty. All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.
OTHERBladder distension groupPatients in the bladder distension group will be instructed to drink one liter of water and to avoid urination during a period of 2 h before the scheduled procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is distended . All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.

Timeline

Start date
2024-10-15
Primary completion
2025-06-15
Completion
2025-06-15
First posted
2024-08-16
Last updated
2024-08-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06558370. Inclusion in this directory is not an endorsement.